SUNPHARMA vs CIPLA Comparison
Head-to-head financial analysis: Sun Pharmaceutical Industries Limited versus Cipla Limited. Prices as of Close on 16 Oct 2026 (NSE/BSE EOD).
SUNPHARMA(NSE/BSE)
Sun Pharmaceutical Industries Limited
Close on 16 Oct 2026
₹1,758.80
1D Change
-0.29%
Market Cap
₹4.22 Lakh Cr
CIPLA(NSE/BSE)
Cipla Limited
Close on 16 Oct 2026
₹1,325.10
1D Change
-0.22%
Market Cap
₹1.05 Lakh Cr
Normalized 1-Year Performance Trajectory
Relative percentage return comparison rebased to 0% at period start.
SUNPHARMA:+6.0%
CIPLA:-15.6%
16 Oct 202521 Apr 202616 Oct 2026
Key Financial Multiples & Trailing Returns Comparison
Factual Data Only| Metric / Ratio | SUNPHARMA | CIPLA |
|---|---|---|
| Trailing P/E Ratio | 34.9x | 31.2x |
| Price-to-Book (P/B) | 5.0x | 3.0x |
| Dividend Yield | 0.91% | 1.00% |
| 52-Week Range | ₹1589 – ₹2001 | ₹1192 – ₹1664 |
| 1-Year Return | +6.0% | -15.6% |
| 3-Year Return | +54.9% | +13.8% |
| 5-Year Return | +110.4% | +46.6% |
| Annualized Volatility (1Y) | 19.3% | 20.6% |
| Beta vs Benchmark (1Y) | 0.46 (NIFTY 50) | 0.59 (NIFTY 50) |
| Max Drawdown (1Y) | -13.2% | -28.3% |